MUC1 immunoexpression is a virtually constant feature of clear cell renal cell carcinoma metastatic to the pancreas.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Advances in Anatomic Pathology

• Publication date

  2012-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/PAP.0b013e318248bd97PMID 22313840
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunohistochemical Distinction of Primary Adrenal Cortical Lesions From Metastatic Clear Cell Renal Cell Carcinoma: A Study of 248 Cases

  2011cited by this paper
• Specificity of brachyury in the distinction of chordoma from clear cell renal cell carcinoma and germ cell tumors: a study of 305 cases

  2011cited by this paper
• A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings

  2011cited by this paper
• Immunohistochemical diagnosis of renal neoplasms.

  2011cited by this paper
• Analysis of Prognostic Factors in Metastatic Tumors of the Pancreas: A Single-Center Experience and Review of the Literature

  2010cited by this paper
• The Use of Immunohistochemistry in the Diagnosis of Metastatic Clear Cell Renal Cell Carcinoma: A Review of PAX-8, PAX-2, hKIM-1, RCCma, and CD10

  2010cited by this paper
• Metastatic tumors in the pancreas in the modern era.

  2010cited by this paper
• Significance of mucin expression in pancreatobiliary neoplasms

  2010cited by this paper
• Differential diagnosis of renal tumours with clear cell histology.

  2010cited by this paper
• MUC1, a new hypoxia inducible factor target gene, is an actor in clear renal cell carcinoma tumor progression.

  2009cited by this paper
• The Utility of PAX-2 in Distinguishing Metastatic Clear Cell Renal Cell Carcinoma From its Morphologic Mimics: An Immunohistochemical Study With Comparison to Renal Cell Carcinoma Marker

  2008cited by this paper
• Diffuse expression of MUC1 in metastases of renal clear cell carcinoma as a possible therapeutic target for renal cancer

  2005cited by this paper
• Expression of MUC1 (EMA) and E-cadherin in renal cell carcinoma: a systematic immunohistochemical analysis of 188 cases

  2004cited by this paper
• MUC1 expression is correlated with nuclear grade and tumor progression in pT1 renal clear cell carcinoma.

  2002cited by this paper
• Expression of human mucin genes in normal kidney and renal cell carcinoma

  2002cited by this paper
• MUC1 mucin and trefoil factor 1 protein expression in renal cell carcinoma: correlation with prognosis.

  2002cited by this paper
• Foamy gland pattern of pancreatic ductal adenocarcinoma: a deceptively benign-appearing variant.

  2000cited by this paper
• Expression of MUC1, Thomsen-Friedenreich-related antigens, and cytokeratin 19 in human renal cell carcinomas and tubular clear cell lesions

  2000cited by this paper
• Expression of MUC1 mucins inversely correlated with post-surgical survival of renal cell carcinoma patients

  1999cited by this paper
• Clear cell carcinoma of the pancreas: an adenocarcinoma with ductal phenotype

  1998cited by this paper
• Immunohistochemical differentiation of metastatic breast carcinomas from metastatic adenocarcinomas of other common primary sites

  1996cited by this paper

• Lewis(y) antigen promotes the progression of epithelial ovarian cancer by stimulating MUC1 expression

  2017cites this paper
• A new age for vaccine therapy in renal cell carcinoma.

  2013cites this paper